NasdaqGM - Delayed Quote USD

Merrimack Pharmaceuticals, Inc. (MACK)

14.72 +0.04 (+0.27%)
At close: April 19 at 4:00 PM EDT
14.68 -0.04 (-0.27%)
After hours: April 19 at 7:03 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Gary L. Crocker M.B.A. President, Treasurer, Principal Financial Officer, Principal Accounting Officer, CEO & Chairman 76k -- 1952
Dr. Ulrik B. Nielsen Ph.D. Co-Founder & Independent Director 72.5k -- 1972
Dr. Anthony J. Sinskey Ph.D., Sc.D. Co-Founder and Scientific Advisor 4.25k -- 1940
Mr. Timothy R. Surgenor Secretary -- -- 1960

Merrimack Pharmaceuticals, Inc.

One Broadway
14th Floor
Cambridge, MA 02142
United States
617 720 8606 https://www.merrimack.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Merrimack Pharmaceuticals, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 9. The pillar scores are Audit: 8; Board: 10; Shareholder Rights: 7; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024 - May 06, 2024
Merrimack Pharmaceuticals, Inc. Earnings Call

Related Tickers

ESLA Estrella Immunopharma, Inc.
1.0700
+4.90%
 
INBX Inhibrx, Inc.
34.32
-0.38%
 
RPHM Reneo Pharmaceuticals, Inc.
1.7400
-1.14%
 
ADAG Adagene Inc.
2.6400
+2.33%
 
OBIO Orchestra BioMed Holdings, Inc.
4.6400
-1.49%
 
MLEC Moolec Science SA
1.4000
+1.45%
 
TIL Instil Bio, Inc.
10.64
+3.30%
 
AVTE Aerovate Therapeutics, Inc.
22.05
+2.08%
 
LRMR Larimar Therapeutics, Inc.
6.53
+2.35%
 
PHAR Pharming Group N.V.
10.00
+4.00%